Prostate Cancer,,Version 2.2014 Clinical Practice Guidelines in Oncology

James L. Mohler, Philip W. Kantoff, Andrew J. Armstrong, Robert R. Bahnson, Michael Cohen, Anthony Victor D'Amico, James A. Eastham, Charles A. Enke, Thomas A. Farrington, Celestia S. Higano, Eric Mark Horwitz, Christopher J. Kane, Mark H. Kawachi, Michael Kuettel, Timothy M. Kuzel, Richard J. Lee, Arnold W. Malcolm, David Miller, Elizabeth R. Plimack, Julio M. Pow-SangDavid Raben, Sylvia Richey, Mack Roach, Eric Rohren, Stan Rosenfeld, Edward Schaeffer, Eric J. Small, Guru Sonpavde, Sandy Srinivas, Cy Stein, Seth A. Strope, Jonathan Tward, Dorothy A. Shead, Maria Ho

Research output: Contribution to journalArticlepeer-review

285 Scopus citations

Abstract

Prostate cancer has surpassed lung cancer as the most common cancer in men in the United States. The NCCN Guidelines for Prostate Cancer provide multidisciplinary recommendations on the clinical management of patients with prostate cancer based on clinical evidence and expert consensus. NCCN Panel guidance on treatment decisions for patients with localized disease is represented in this version. Significant updates for early disease include distinction between active surveillance and observation, a new section on principles of imaging, and revisions to radiation recommendations. The full version of these guidelines, including treatment of patients with advanced disease, can be found online at the NCCN website.

Original languageEnglish (US)
Pages (from-to)686-718
Number of pages33
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume12
Issue number5
StatePublished - 2014

ASJC Scopus subject areas

  • Oncology
  • General Medicine

Fingerprint

Dive into the research topics of 'Prostate Cancer,,Version 2.2014 Clinical Practice Guidelines in Oncology'. Together they form a unique fingerprint.

Cite this